The patient is a 57-year-old, right-handed, retired postal worker. He
presented with a chief complaint of left-sided facial tingling. The episodes of
paresthesia last only a few seconds, but have persisted for 7 years.
There have also been episodes of dizziness and imbalance. He denied
headaches. His only significant past medical history includes hypertension and
anxiety disorder.
On physical examination, no cranial nerve deficit was evident.
Specifically, sensory and motor function of the trigeminal nerve and
extraocular muscle function were intact.
MRI of the brain demonstrated a T2 hyperintense, heterogeneously
enhancing, destructive mass centered at the left petroclival synchondrosis.
There was anterior displacement of the petrous segment of the internal carotid
artery, as well as partial effacement of the left Meckel’s cave. There was
a small component of posterior extension into the left prepontine cistern. The
superior portion of the tumor extended into the left middle cranial fossa,
without parenchymal edema in the adjacent temporal lobe. The superior portion
of the tumor had stronger enhancement than the inferior portion.
A preoperative postcontrast, high-resolution CT examination exhibited
osseous destruction centered at the foramen lacerum, involving the lateral
clivus and medial petrous apex. The superior component of the tumor contained
punctate and arc-like areas of calcification (in contrast to the irregular
remnants of the destroyed portion of the petrous apex). The superior component
of the tumor also had slightly higher attenuation than the inferior component
of the tumor, which may reflect higher density, enhancement or a combination.
|
 Axial postcontrast CT images. Panel A shows
relatively higher attenuation of the tumor in its craniad component, adjacent
to the medial temporal lobe. There are curvilinear hyperdensities (arrow)
consistent with chondroid matrix. Panel B shows a more hypodense inferior
portion of the tumor (arrowhead), anterior to the partially destroyed petrous
apex.
Photos courtesy of M. Ghesani, MD
|
|
 Axial postcontrast
T1-weighted images with fat saturation. Panel A shows relatively brisk
enhancement of the superior portion of the tumor (arrow), corresponding to the
area of calcifications seen in Figure 1A. Note anteromedial displacement of the
flow void for the left internal carotid artery (short arrow in panel A). Panel
B shows a lesser degree of enhancement at the inferior portion of the tumor
(arrowhead), corresponding to Figure 1B, with mild extension into the
prepontine cistern. |
|
 Coronal reformatted image from the CT examination shown in Figure 1, bone algorithm (panel A). The curvilinear calcifications in the superior portion of the tumor (arrow) are consistent with a tumor of chondroid origin. Coronal T2 weighted image (panel B) shows signal hyperintensity of the tumor. |
|
 Chondrosarcoma. Most areas of the tumor consist of a cellular proliferation of small rounded chondrocytes distributed in a copious myxoid matrix (panel A, H&E, 100x). These cells are focally arranged in cords and trabeculae, have pale eosinophilic to clear cytoplasm, and slightly enlarged nuclei with occasional binucleation. Some areas of the tumor show more obvious cartilaginous differentiation with lobules of well-formed hyaline cartilage (arrows in panel B, H&E, 100x) and entrapped trabecular bone (left lower quadrant of panel B). |
The patient underwent surgical resection of the tumor. Histologic
findings were consistent with a chondrosarcoma (CSA), predominantly myxoid
type. Distinguishing the tumor from chordoma, the main differential diagnostic
consideration, was difficult and required the use of multiple immunohistologic
stains.
Although CSA may account for up to one-third of primary bone
malignancies, the intracranial variety is much rarer, making up less than 1% of
all intracranial tumors. Origin from rests of fetal cartilage, which are
remnants of intramembranous ossification of endochondral bone, gives CSA a
predilection for the petroclival, sphenopetrosal, petro-occipital and
spheno-occipital synchondroses of the skull base. CSA may also arise from
malignant degeneration of enchondroma, as in Ollier’s disease and
Maffucci’s syndrome.
The clinical presentation of CSA will largely depend on the specific
anatomic areas involved. Headache is common. More specific symptoms that point
to involvement of particular cranial nerves are common, especially diplopia due
to involvement of the abducens nerve as it crosses the petrous apex, or facial
pain due to the tumor’s proximity to Meckel’s cave and the cavernous
sinus, involving the trigeminal nerve.
Virtually all skull base CSA are of the conventional type, which may be
composed of myxoid matrix, hyaline matrix or, most often, a combination of the
two. The hyaline type has a more solid tumor matrix than the myxoid type and
may feature calcifications that characteristically take a curvilinear shape on
imaging, often described as “rings and arcs.” Matrix calcifications
may be seen in about one-half of cases of skull base CSA.
As in this case, lobulated morphology with T2 hyperintensity on MRI is
characteristic. Bone destruction is evident on CT in most cases. In this case,
the tumoral component with stronger CT hyperdensity and gadolinium enhancement,
as well as calcifications, likely represents an area of hyaline matrix, whereas
the component with relative CT hypodensity and less brisk contrast enhancement
is likely composed predominantly of myxoid matrix.
Daniel E. Meltzer, MD, is an assistant professor of radiology at St
Luke’s-Roosevelt Hospital Center.
Ali Noor, MD, is a resident, PG-4, diagnostic radiology at St
Luke’s-Roosevelt Hospital Center.
Yinghua Pang, MD, is a resident, PGY-3, anatomical and clinical
pathology at St Luke’s-Roosevelt Hospital Center.
Arzu Buyuk, MD, is an assistant professor of pathology at St
Luke’s-Roosevelt Hospital Center and Roosevelt Hospital Surgical
Pathology.
Munir Ghesani, MD, is an attending radiologist at St.
Luke’s-Roosevelt Hospital Center and associate clinical professor of
radiology at Columbia University College of Physicians and Surgeons.
For more information:
- Berkmen Y. Clin Radiol. 1968;19:327-33.
- Lau DP. Dilemmas in diagnosis and treatment. J Laryngol
Otol. 1997;111:368-71.
- Neff B. Laryngoscope. 2002;112:134-139.
- Pamir MN. European Journal of Radiology. 2006;
58:461-470.
- Rosenberg AE. Am J Surg Pathol.1999;23(11):1370-1378.
- Som PM. Head and Neck Imaging. 4th ed. St. Louis, MO:
Mosby, 2003.
Disclosures: The authors report no relevant financial
disclosures.